Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
基本信息
- 批准号:10185144
- 负责人:
- 金额:$ 120万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAcademic Medical CentersAffectAgricultureAppalachian RegionArtsClinicalClinical ResearchClinical SciencesClinical TrialsClinical Trials NetworkCollaborationsCommunitiesDataDevelopmentDisciplineDiverse WorkforceEducationEngineeringEnvironmentFosteringFutureGoalsHealthHealthcareHealthcare SystemsHome environmentInformaticsInstitutesInstitutionInterdisciplinary StudyKentuckyLeadLeadershipLongevityMedical centerMethodologyMissionMulti-Institutional Clinical TrialParticipantPatient RecruitmentsPersonal SatisfactionPhasePopulationPositioning AttributeQuality of CareQuality of lifeResearchResearch TrainingRoleRuralRural CommunityRural PopulationScholarshipScienceSolidTarget PopulationsTranslational ResearchTrustUniversitiesWest VirginiaWorkforce Developmentbasebiomedical informaticscatalystclinical centercohesioncollaborative environmentcollegedata managementdata warehousedrug developmentfood environmenthealth care service organizationhealth disparityhealthcare communityimprovedinnovationmedical schoolsmedically underservednamed groupnovelnovel therapeuticsprogramsrural areasuccess
项目摘要
Contact PD/PI: Kern, Philip A
PROJECT SUMMARY
The University of Kentucky (UK) Center for Clinical and Translational Science (CCTS) has created an
integrated home for clinical and translational research to promote scientific progress and discoveries at every
phase of the translational continuum. The CCTS has fundamentally transformed the research environment not
only at UK but throughout Central Appalachia through the development of a strong research network, the
Appalachian Translational Research Network (ATRN), with integrated research partnerships including other
CTSA hubs. When combined with an in-depth understanding of the unique and serious health challenges
faced by Central Appalachian residents, the UK CCTS is positioned to lead local, regional and national
research efforts that focus on the significant health disparities in this population. Our overarching goal as a
CTSA hub is to continue to champion innovation in the full spectrum of clinical and translational research while
educating the workforce of the future, engaging our communities in biomedical science and working with the
national network to advance cohesive multi-center clinical trials, which will ultimately elevate the health and
quality of life of the populace of Central Appalachia. Specifically, the UK CCTS will: 1) Lead institutional
innovation in the delivery of efficient, effective clinical and translational research. 2) Develop a diverse
workforce across multiple disciplines that advances translational research and excels in team-based science.
3) Meet the unique needs of Central Appalachian residents by extensively engaging and collaborating with our
regional, rural and community-based partners. 4) Catalyze innovative research, including novel drug
development and informatics methodologies, with particular focus on bringing innovation to special populations
and across the lifespan. 5) Create an efficient clinical trials network, centered at UK, and extending into our
partner health care systems that will be an essential and leading component of the CTSA consortium, involving
participants throughout a four state region of rural Central Appalachia. The UK CCTS benefits from a
collaborative environment found on only a few university campuses. UK has 16 colleges, with 11 involved in
the UK CCTS (including six biomedical colleges) on one central campus. This physical proximity of our
academic and health care communities, along with a culture of collaboration, creates a closely knit unified
academic community and positions the UK CCTS to demonstrate the impact of collaborative translational
research and leadership in team science. Our efforts have already been successful at transforming the culture
of the UK academic medical center to one that more keenly appreciates scholarship, innovation and
translational science. We now plan to build on these strengths to advance translational science to the next
level, with further development of our clinical trial networks, development of novel informatics programs, and
continued development of the workforce throughout the region. These efforts will benefit the medically
underserved residents of Central Appalachia and will significantly contribute to the national CTSA program.
1
Project Summary/Abstract Page 287
Contact PD/PI: Kern, Philip A
联系PD/PI: Kern, Philip A
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Philip A Kern其他文献
Philip A Kern的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Philip A Kern', 18)}}的其他基金
Mirabegron and tadalafil effectiveness for treatment of prediabetes
米拉贝隆和他达拉非治疗糖尿病前期的有效性
- 批准号:
10363388 - 财政年份:2021
- 资助金额:
$ 120万 - 项目类别:
Mirabegron and tadalafil effectiveness for treatment of prediabetes
米拉贝隆和他达拉非治疗糖尿病前期的有效性
- 批准号:
10532229 - 财政年份:2021
- 资助金额:
$ 120万 - 项目类别:
Mechanisms for activation of beige adipose tissue in humans
人体米色脂肪组织的激活机制
- 批准号:
10531210 - 财政年份:2020
- 资助金额:
$ 120万 - 项目类别:
Mechanisms for Activation of Beige Adipose Tissue in Humans; Supplement
人类米色脂肪组织的激活机制;
- 批准号:
10630687 - 财政年份:2020
- 资助金额:
$ 120万 - 项目类别:
Mechanisms for activation of beige adipose tissue in humans
人体米色脂肪组织的激活机制
- 批准号:
10308496 - 财政年份:2020
- 资助金额:
$ 120万 - 项目类别:
The activation of brown and beige fat and role in insulin sensitivity
棕色和米色脂肪的激活及其在胰岛素敏感性中的作用
- 批准号:
9241565 - 财政年份:2016
- 资助金额:
$ 120万 - 项目类别:
Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
- 批准号:
10459638 - 财政年份:2016
- 资助金额:
$ 120万 - 项目类别:
Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
- 批准号:
10681386 - 财政年份:2016
- 资助金额:
$ 120万 - 项目类别:
Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
- 批准号:
9314011 - 财政年份:2016
- 资助金额:
$ 120万 - 项目类别:
Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
- 批准号:
10733214 - 财政年份:2016
- 资助金额:
$ 120万 - 项目类别:
相似海外基金
Building a Systems Approach to Community Health and Health Equity for Academic Medical Centers
为学术医疗中心建立社区健康和健康公平的系统方法
- 批准号:
9212055 - 财政年份:2016
- 资助金额:
$ 120万 - 项目类别:
Building a Systems Approach to Community Health and Health Equity for Academic Medical Centers
为学术医疗中心建立社区健康和健康公平的系统方法
- 批准号:
9348616 - 财政年份:2016
- 资助金额:
$ 120万 - 项目类别:
A CONFERENCE ON THE 'CRISIS' OF ACADEMIC MEDICAL CENTERS
关于学术医疗中心“危机”的会议
- 批准号:
6335654 - 财政年份:2000
- 资助金额:
$ 120万 - 项目类别:














{{item.name}}会员




